Search results for "BIP"

showing 10 items of 1908 documents

The effect of concomitant benzodiazepine use on neurocognition in stable, long-term patients with bipolar disorder

2020

Objective: Neurocognitive dysfunction is a common feature of bipolar disorder even in euthymia, and psychopharmacological treatment could have an effect on cognition. Long-term prescription of benzodiazepines in bipolar disorder is a common practice, and their effect on neurocognition has not been well studied in this population. The aim of this study was to evaluate the impact of concomitant benzodiazepine long-term use on neurocognitive function in stable euthymic bipolar disorder patients. Methods: Seventy-three euthymic bipolar disorder outpatients and 40 healthy individuals were assessed using a neurocognitive battery. Patients were classified in two groups according to the presence of…

medicine.medical_specialtyBipolar Disordermedicine.drug_classNeuropsychological TestsBenzodiazepinesExecutive Function03 medical and health sciencesCognition0302 clinical medicinemedicineHumansBipolar disorderMedical prescriptionPsychiatryBenzodiazepinebusiness.industryCognitionGeneral Medicinemedicine.disease030227 psychiatryTerm (time)Psychiatry and Mental healthFeature (computer vision)ConcomitantbusinessNeurocognitive030217 neurology & neurosurgeryAustralian & New Zealand Journal of Psychiatry
researchProduct

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysi…

2010

In recent years, combinations of pharmacological treatments have become common for the treatment of bipolar disorder type I (BP I); however, this practice is usually not evidence-based and rarely considers monotherapy drug regimen (MDR) as an option in the treatment of acute phases of BP I. Therefore, we evaluated comparative data of commonly prescribed MDRs for both manic and depressive phases of BP I. Medline, PsycINFO, EMBASE, the Cochrane Library, the ClinicalStudyResults.org and other data sources were searched from 1949 to March 2009 for placebo and active controlled randomized clinical trials (RCTs). Risk ratios (RRs) for response, remission, and discontinuation rates due to adverse …

medicine.medical_specialtyBipolar I disorderBipolar DisorderDatabases FactualPharmacologyLithiumArticlelaw.inventionTreatment of bipolar disorderRandomized controlled triallawInternal medicinemental disordersmedicineAnimalsHumansManic-depressive illnessPharmacology (medical)Bipolar disorderAntipsychotic drugsRandomized Controlled Trials as TopicPharmacologyTrastorn bipolarbusiness.industrymedicine.diseaseLitiAntidepressive AgentsDiscontinuationPsychiatry and Mental healthAcute DiseaseNumber needed to treatAnticonvulsiusQuetiapineDrug EvaluationAntipsicòticsAnticonvulsantsmedicine.symptombusinessManiamedicine.drug
researchProduct

Comparing neurocognitive impairment in schizophrenia and bipolar I disorder using the Screen for Cognitive Impairment in Psychiatry Scale

2014

AbstractThe purpose of this study was to compare the psychometric properties of the Screen for Cognitive Impairment in Psychiatry (SCIP) when applied to patients diagnosed with schizophrenia (n=126) or bipolar I disorder (n=76), and also to compare the cognitive impairment in both samples of patients and a control group (n=83) using the SCIP and a complete neuropsychological battery. The SCIP is a scale intended to quickly and easily assess cognitive impairment in patients with severe psychiatric disorders. The results showed firstly that, in terms of internal consistency, temporal stability, dimensional structure, and criterion-referenced validity, the SCIP provides reliable and valid scor…

medicine.medical_specialtyBipolar I disorderCognition disordersBipolar disorderlcsh:BF1-990EsquizofreniaDeterioro cognitivoTrastorns de la cognicióInstrumental studymedicineManic-depressive illnessIn patientBipolar disorderCognitive impairmentPsychiatryTrastorn bipolarTrastorno bipolarEstudio instrumentalNeuropsychological batterymedicine.diseaseScreen for Cognitive Impairment in PsychiatryClinical PsychologyCognitive impairmentlcsh:PsychologySchizophreniaSchizophreniaEsquizofrèniaVerbal memoryPsychologyNeurocognitiveInternational Journal of Clinical and Health Psychology
researchProduct

Neurocognitive impairment and psychosocial functioning in bipolar II disorder

2011

Sole B, Bonnin CM, Torrent C, Balanza-Martinez V, Tabares-Seisdedos R, Popovic D, Martinez-Aran A, Vieta E. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Objective:  There is a growing body of evidence on neurocognitive impairment in euthymic bipolar patients, but this issue has been studied mostly in bipolar I disorder, data on bipolar II (BD-II) are scant and discrepant. The two aims of this study were to ascertain whether strictly defined euthymic BD-II patients would present neurocognitive disturbances and to evaluate their impact on functional outcome. Method:  Forty-three BD-II patients and 42 demographically and educationally matched healthy subjects …

medicine.medical_specialtyBipolar I disorderTrail Making TestHamilton Rating Scale for DepressionVerbal learningmedicine.diseaseYoung Mania Rating ScalePsychiatry and Mental healthBipolar II disorderHypomaniamedicinemedicine.symptomPsychologyPsychiatryNeurocognitiveActa Psychiatrica Scandinavica
researchProduct

Characteristics of bipolar disorder patients given antidepressants

2012

Evidence concerning efficacy of antidepressants in bipolar disorder remains inconsistent and inconclusive. As the appropriate clinical use for such patients remains unclear, we characterized outpatients with bipolar disorders who were or were not treated with antidepressants. Clinical data were collected systematically from consecutive outpatients in 11 participating Argentine mood-disorder clinics in 2007–2008. Diagnoses met DSM-IV criteria, supported by structured interviews based on the MINI-500. Of 338 outpatients diagnosed with bipolar I (45.0%), II (29.3%), or not-otherwise-specified (NOS) (25.7%) disorder, 128 (37.9%) received antidepressants. Subjects given antidepressants or not di…

medicine.medical_specialtyBipolar I disorderbusiness.industrymedicine.diseaseAntimanic AgentsPsychiatry and Mental healthNeurologyInternal medicineMedicineOutpatient clinicAntidepressantPharmacology (medical)Neurology (clinical)Bipolar disorderbusinessPsychiatryDepression (differential diagnoses)Human Psychopharmacology: Clinical and Experimental
researchProduct

Neurocognition in bipolar disorders—A closer look at comorbidities and medications

2010

The last decade has witnessed a growing interest in the neuropsychological study of bipolar disorder (BD). This chronic mood disorder is associated with persistent neurocognitive impairments even during periods of euthymia, particularly in the broad domains of attention, verbal memory and executive functions. More interestingly, cognitive dysfunction seems to predict a poorer functional outcome among BD patients and thus represents an important target for future therapies. The aetiology of cognitive dysfunction is probably multifactorial, including gene-environment interactions with potentially confounding variables as well. Drug-induced cognitive adverse effects represent an important and …

medicine.medical_specialtyBipolar disorderComorbidityLithiumAntipsychoticNeuropsychologyAnticonvulsantmedicineAnimalsHumansBipolar disorderPsychiatryPharmacologyNeuropsychologyCognitionIatrogenic effectmedicine.diseaseExecutive functionsComorbidityPharmaceutical PreparationsObservational studyVerbal memoryCognition DisordersPsychologyNeurocognitiveClinical psychologyEuropean Journal of Pharmacology
researchProduct

How common is bipolar disorder in general primary care attendees? A systematic review and meta-analysis investigating prevalence determined according…

2016

Objective: There are mounting calls for bipolar disorder to be managed in primary care, yet the exact prevalence remains unclear. We conducted a meta-analysis to investigate the prevalence of bipolar disorder in general primary care attendees without other comorbid psychiatric diagnosis. Method: We systematically searched major electronic databases from inception till 03/2015. Articles were included that reported the prevalence of bipolar disorder determined in line with structured clinical assessment in primary care settings. Two independent authors conducted searches, completed methodological appraisal and extracted data. A random effects meta-analysis and meta-regression were performed. …

medicine.medical_specialtyBipolar disorderPrimary careComorbidity03 medical and health sciences0302 clinical medicinePrevalence of mental disordersmedicinePrevalenceHumans030212 general & internal medicineBipolar disorderPsychiatryaffective disorderPrimary Health Carebusiness.industryMean ageGeneral MedicineRandom effects modelmedicine.diseaseAffective disorders; Bipolar disorder; Prevalence; Primary care; Psychiatry and Mental HealthPrimary careComorbidityConfidence interval030227 psychiatryAffective disordersEuropePsychiatry and Mental HealthMeta-analysisNorth AmericaBipolar disorder prevalence primary care affective disordersbusinessHuman
researchProduct

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analys…

2017

People with severe mental illness (SMI) – schizophrenia, bipolar disorder and major depressive disorder – appear at risk for cardiovascular disease (CVD), but a comprehensive meta-analysis is lacking. We conducted a large-scale meta-analysis assessing the prevalence and incidence of CVD; coronary heart disease; stroke, transient ischemic attack or cerebrovascular disease; congestive heart failure; peripheral vascular disease; and CVD-related death in SMI patients (N=3,211,768) versus controls (N=113,383,368) (92 studies). The pooled CVD prevalence in SMI patients (mean age 50 years) was 9.9% (95% CI: 7.4-13.3). Adjusting for a median of seven confounders, patients had significantly higher o…

medicine.medical_specialtyCardiovascular disease; bipolar disorder; cerebrovascular disease; congestive heart failure; coronary heart disease; major depression; premature mortality; schizophrenia; severe mental illness03 medical and health sciences0302 clinical medicinesevere mental illnessMedicineCardiovascular disease severe mental illness schizophrenia bipolar disorder major depression coronary heart disease cerebrovascular disease congestive heart failure premature mortalitycoronary heart diseasePsychiatrybipolar disorderFramingham Risk Scorebusiness.industryVascular diseaseIncidence (epidemiology)Hazard ratioCorrectionOdds ratiomedicine.diseaseCardiovascular disease030227 psychiatrycerebrovascular diseaseschizophreniaPsychiatry and Mental healthcongestive heart failurepremature mortalityHeart failureMajor depressive disorderPshychiatric Mental Healthbusinessmajor depressionBody mass index030217 neurology & neurosurgery
researchProduct

A meta-analysis of temperament and character dimensions in patients with mood disorders: Comparison to healthy controls and unaffected siblings

2016

Background Cloninger's psychobiological model of personality has been extensively applied to subjects affected by mood disorders (MOOD). However, most studies are widely heterogeneous in terms of sample size, methods of assessment, and selection of participants. Methods We conducted a systematic review of literature and a random effects meta-analysis of studies comparing at least two of the following groups: (a) adults with a primary MOOD diagnosis (Bipolar Disorder (BP) or major depressive disorder (MDD)), (b) their unaffected siblings (SIB) or (c) healthy subjects (HS), and reporting quantitative results from the Tridimensional Personality Questionnaire (TPQ) or the Temperament and Charac…

medicine.medical_specialtyCharacterBipolar DisorderPersonality InventoryTraitTridimensional Personality QuestionnaireNO03 medical and health sciences0302 clinical medicineHarm ReductionmedicineHumansPsychiatryTemperamentDepressive Disorder MajorDepressionMood DisordersSiblingsCooperativenessNovelty seekingmedicine.diseaseTemperament Character Depression Mood disorders Bipolar Disorder Trait State030227 psychiatryClinical PsychologyMoodReward dependenceMood disordersPsychiatry and Mental HealthCase-Control StudiesHarm avoidanceRegression AnalysisTemperament and Character InventoryPsychologyBipolar Disorder; Character; Depression; Mood disorders; State; Temperament; Trait; Psychiatry and Mental Health; Clinical Psychology030217 neurology & neurosurgeryStateClinical psychology
researchProduct

Clinical risk factors for bipolar disorders: A systematic review of prospective studies

2014

Background: Early phases and suspected precursor states of bipolar disorder are not well characterized. We evaluate the prevalence, duration, clinical features and predictive value of non-affective psychopathology as clinical risk factors for bipolar disorder in prospective studies. Methods: We screened PubMed, CINAHL, PsycINFO, Embase, SCOPUS, and ISI-Web of Science databases from inception up to January 31, 2014, following PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and searched: bipolar disorder AND [antecedentn OR predictn OR prodromn OR prospectn OR riskn] AND [diagnosis OR development]. We included only English language reports on prospective…

medicine.medical_specialtyComorbidityImpulsivityTreatment of bipolar disorderchild; prodrome; adolescent; bipolar disorder; risk factor; depressionPrevalence of mental disordersRisk Factorsmental disordersPrevalencemedicineHumansProspective StudiesBipolar disorderRisk factorPsychiatryRetrospective Studiesbipolar disorderchildmedicine.diseaseAnxiety DisordersprodromePsychiatry and Mental healthClinical PsychologySystematic reviewrisk factorAttention Deficit Disorder with HyperactivityadolescentImpulsive BehaviordepressionPanic DisorderAnxietyFemaleCrimemedicine.symptomPsychologyPsychopathologyClinical psychologyJournal of Affective Disorders
researchProduct